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Allen D. Hamdan, MD, Raul J. Guzman, MD, and Marc L. Schermerhorn, MD, Boston, Mass
Objective: Readmission is associated with high mortality, morbidity, and cost. We used the American College of Surgeons
National Surgery Quality Improvement Program (ACS-NSQIP) to determine risk factors for readmission after lower
extremity bypass (LEB).
Methods:We identiﬁed all patients who received LEB in the 2011 ACS-NSQIP database. Multivariable logistic regression
was used to assess independent predictors of 30-day readmission. We also identiﬁed our institutional contribution of LEB
patients to the ACS-NSQIP from 2005 to 2011 to determine our institution’s rate of readmission and readmission
indications.
Results: Among 5018 patients undergoing LEB, ACS-NSQIP readmission analysis was performed on 4512, excluding
those whose readmission data were unavailable, who suffered a death on index admission, or who remained in the
hospital at 30 days. Overall readmission rate was 18%, and readmission rate of those with NSQIP-captured complications
was 8%. Multivariable predictors of readmission were dependent functional status (odds ratio [OR], 1.40; 95% conﬁ-
dence interval [CI], 1.08-1.79), dyspnea (OR, 1.28; 95% CI, 1.02-1.60), cardiac comorbidity (OR, 1.46; 95% CI, 1.16-
1.84), dialysis dependence (OR, 1.44; 95% CI, 1.05-1.97), obesity (OR, 1.28; 95% CI, 1.07-1.53), malnutrition (OR,
1.42; 95% CI, 1.12-1.79), critical limb ischemia operative indication (OR, 1.40; 95% CI, 1.10-1.79), and return to the
operating room on index admission (OR, 8.0; 95% CI, 6.68-9.60). The most common postdischarge complications
occurring in readmitted patients included wound complications (55%), multiple complications (22%), and graft failure
(5%). Our institutional data contributed 465 LEB patients to the ACS-NSQIP from 2005 to 2012, with an overall
readmission rate of 14%. Unplanned readmissions related to the original LEB (related unplanned) made up 75% of cases.
The remainder 25% included readmissions that were planned staged procedures related to the original LEB (related
planned, 11%) and admissions for a completely unrelated reason (unrelated unplanned, 14%). The most common
readmission indications included wound infection (37%) and graft failure (10%). Readmissions were attributable to
NSQIP-captured postdischarge complications in 44% of cases, an additional 44% had a non-NSQIP-deﬁned reason for
readmission, and the remainder (12%) included patients admitted for complications described in NSQIP but not meeting
strict NSQIP criteria.
Conclusions: Readmissions are common after LEB. Optimization of select chronic conditions, closer follow-up of patients
in poor health and those who required return to the operating room, and early detection of surgical site infections may
improve readmission rates. Our ﬁnding that 25% of readmissions after LEB are not procedure related informs the broader
discussion of how a readmission penalty affects vascular surgery in particular. (J Vasc Surg 2014;59:1331-9.)The Medicare Payment Advisory Commission estimates
Medicare expenditures for potentially preventable rehospi-
talizations to be as high as $12 billion annually.1 As a result,
the Medicare Payment Advisory Commission has put forth
recommendations to determine payments partially based
on readmission rates.1,2 According to these recommenda-
tions, hospitals with high risk-adjusted rehospitalizationthe Department of Vascular Surgery, Beth Israel Deaconess Medical
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This has led to increased interest in studying rehospitaliza-
tion rates and contributing factors. Readmission data have
already changed health care review in other countries. The
Australian Council on Healthcare Standards uses readmis-
sion rates as an internal marker of problems in patient man-
agement and outcomes, which eventually led to review of
one third of hospitals.3 In the British National Health Ser-
vice, acute readmissions are known as failed discharges,
indicating a deﬁcit in the quality of care received during
the index admission.2 Studies have concluded lower quality
of inpatient care to be associated with higher readmission
rates.4
A 2009 New England Journal of Medicine study of
12 million Medicare beneﬁciaries by Jencks et al5 reported
a 30-day readmission rate of 24% for patients undergoing
surgery for peripheral vascular disease, third highest of
any diagnosis-related group behind only congestive heart
failure (CHF) and psychoses. Subsequent studies further1331
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Jackson et al6 reported low rehospitalization rates for
vascular surgery patients at a single institution, with 12%
overall readmission rate and 9% unplanned rehospitaliza-
tion rate. Other authors have similarly looked at readmis-
sion rates after speciﬁc procedures, such as amputations,
carotid endarterectomy, and abdominal aortic aneurysm,
although the precise relationship between quality and
readmission rates in the area of vascular surgery remains
uncertain.7-15
For lower extremity arterial occlusive disease, Goodney
et al16 showed a readmission rate of 19% for Medicare ben-
eﬁciaries undergoing lower extremity bypass (LEB) in the
late 1990s as part of a larger study evaluating the impact
of hospital volume on readmission. More recently,
McPhee17 found a 23% unplanned readmission rate for pa-
tients undergoing open LEB at a single institution; Vogel18
found a 30% readmission rate after endovascular tibiopero-
neal interventions in Medicare beneﬁciaries with critical
limb ischemia (CLI). Whereas these studies have shed light
on the issue of readmission in this population, readmission
after open LEB, including risk factors for readmission, has
not been studied on the national level with use of clinical
data but rather only with administrative data intended for
billing purposes. With a prospectively collected, clinical
design making use of direct medical record review and pa-
tient contact, we now aim to use the perspective of the
American College of Surgeons National Surgery Quality
Improvement Program (ACS-NSQIP) database to study
the incidence of and risk factors for readmission in patients
undergoing LEB.
METHODS
Data source. We used data from the 2011 ACS-
NSQIP, a national, prospectively collected clinical data-
base with more than 350 member institutions with a
mission of facilitating quality-control review of periopera-
tive outcomes. Clinical nurse reviewers are trained and
certiﬁed by the ACS to input data at each participating
institution using standardized deﬁnitions created by the
ACS. Although not all cases from participating institutions
are included in the database, cases are selected for NSQIP
inclusion on the basis of a systematic sampling system
developed to prevent bias in case selection. The NSQIP
data are subject to a rigorous annual audit process with
validated accuracy.19-21 The 30-day postoperative out-
comes, including posthospitalization information, are
collected from hospital records, clinic visits, and follow-up.
In 2011, the ACS-NSQIP introduced a variable for 30-day
readmission, and for this reason analysis was restricted to
that year only. Given the methodology of NSQIP follow-
up, readmission to any institution, including non-NSQIP
institutions other than where the procedure occurred,
was captured. For patients in whom contact regarding 30-
day outcomes is not possible, the readmission ﬁeld
is marked as unavailable. Whereas the ACS-NSQIP cap-
tures 30-day readmission for all patients, indication forreadmission is not available. As a result, we retrospectively
reviewed our institutional contribution of LEB patients to
the ACS-NSQIP from 2005 to 2012 to determine the rate
of readmission after LEB and to better delineate read-
mission indication. Readmission and indication for read-
mission to our institution were determined for all patients
by physician review of the medical record. After the addi-
tion of readmission as a formal NSQIP parameter in late
2010, readmission to any institution was recorded. This
study was approved by the Institutional Review Board at
the Beth Israel Deaconess Medical Center.
Patients. Patients undergoing infrainguinal LEB as a
principal operative procedure were identiﬁed through query
of the 2011 ACS-NSQIP Participant User File and our
institutional NSQIP contribution from 2005 to 2012 by use
of the following Current Procedural Terminology (CPT)
codes: 35556, 35566, 35571, 35583, 35585, 35587,
35651, 35656, 35666, and 35671. Inclusion criteria
required that an LEB CPT code be listed as the principal
operative procedure. Baseline patient demographics,
comorbidities, operative details, and postoperative course
were extracted from the database. Deﬁnitions for NSQIP
collected data points may be found in the NSQIP user guide
available online.22
Outcomes. Our primary outcome measure was overall
readmission to any hospital within 30 days of surgery. In
the ACS-NSQIP analyses, overall readmission referred to
any readmission event. A readmission was deemed
“complication associated” if the patient had both a read-
mission event and an NSQIP-deﬁned postdischarge
complication. Readmission analysis excluded patients not at
risk for 30-day readmission, including those with deaths
during index admission and those remaining in the hospital
at 30 days. Secondary outcome measures included overall
30-day morbidity and mortality stratiﬁed as either before
discharge or after discharge. With use of our institutional
data, physician chart review determined readmission to our
institution as well as the indication for readmission. Read-
mission indication was then used to classify our institu-
tional readmissions as related or unrelated and planned or
unplanned. Planned readmissions were those admissions
scheduled before a patient’s discharge from the index
admission. Related readmissions included readmissions that
could possibly be attributed to the index procedure.
Measures and terms. Although deﬁnitions for all
NSQIP terms may be found in the NSQIP user guide,
this study also used newly created terms deﬁned here. Pa-
tients were considered to have CLI if they met NSQIP
criteria for “rest pain/gangrene” or an “open wound” at
the time of surgery. Obesity denoted any patient with a
body mass index of $30 kg/m2. Malnutrition referred to
patients with a preoperative albumin level of <3.5 g/dL.
Patients were listed as having a cardiac comorbidity if
they met NSQIP criteria for CHF within the previous
30 days or had a history of myocardial infarction within
6 months before surgery, history of cardiac surgery, or his-
tory of percutaneous cardiac intervention. Any wound
Table I. Demographic characteristics and comorbidities
of LEB patients in the 2011 NSQIP database
All patients
(N ¼ 5018), No. (%)
Mean age 6 SD, years 67.5 6 11.5
Male 3241 (64.8)
Race
White 3690 (74.3)
Black 841 (16.9)
Asian 50 (1.0)
Native American 13 (0.3)
Native Hawaiian/Paciﬁc Islander 10 (0.2)
Unknown 414 (8.3)
Chronic nursing home residence 149 (3.0)
Dependent functional status 528 (10.6)
Diabetes mellitus 2188 (43.6)
Chronic obstructive pulmonary disease 641 (12.8)
Smoking 2092 (41.7)
Cardiac comorbidity 941 (29.0)a
History of revascularization or amputation 1304 (49.0)
CLI 2315 (66.0)a
Dialysis 23 (0.5)
Preoperative SIRS or sepsis 231 (4.6)
ASA class $4 1056 (20.9)
Obesity 1375 (7.8)
Malnutrition 1027 (30.1)
ASA, American Society of Anesthesiologists; CLI, critical limb ischemia;
LEB, lower extremity bypass; NSQIP, National Surgery Quality Improve-
ment Program; SD, standard deviation; SIRS, systemic inﬂammatory
response syndrome.
aPercentages reﬂect valid percentage given missing data.
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NSQIP-deﬁned surgical site infection (SSI), including su-
perﬁcial SSI, deep SSI, organ/space SSI, and dehiscence.
Statistical analysis. All analyses were conducted with
IBM SPSS Statistics version 21.0.0 for Macintosh (IBM
Corp, Armonk, NY). Categorical variables were analyzed
by the c2 or Fisher exact test where appropriate. Contin-
uous variables were compared by two-tailed independent
samples t-test. Cases missing data for any given parameter
were eliminated from consideration for the purposes of
bivariate analysis. Multivariable logistic regression was
performed to determine independent predictors of read-
mission. Predictive models for readmission included only
information available at the time of patient discharge,
which excluded postdischarge complications. All variables
with a P value of less than .10 on bivariate analysis were
included in the model. Any candidate covariate with
missing data was analyzed to assess whether the missing-
ness was associated with the primary outcome, readmission.
Missingness was found not to be associated with the pri-
mary outcome, and thus dummy variables were created to
signify missing data. All dummy variable effect estimates
were then found to be nonsigniﬁcant. The lone exception
to this was the variable indicating albumin level <3.5 g/
dL, which was found to be missing not at random. The
nonrandom missingness of albumin measurements has
been well documented, and for this reason albumin was
removed from consideration in our multivariable model.23
Backward stepwise elimination was used to determine ﬁnal
independent predictors. Throughout all analyses, statistical
signiﬁcance was as determined by a criterion of P < .05.
RESULTS
Demographics and clinical detailsdNSQIP. As
shown in Table I, 5018 patients underwent LEB in the
2011 NSQIP. Mean age was 68 years, with male gender
(64.6%), nonblack ethnicity (83%), and nonsmokers
(58.3%) making up the majority of the cohort. Comor-
bidities are outlined in Table I. A minority had an infra-
popliteal LEB target (42%), and approximately one third
(32%) used nonvein graft material. Further operative detail
may be found in Table II. Discharge was to home in 71% of
cases.
Morbidity and mortalitydNSQIP. The 30-day
mortality rate in the NSQIP cohort was 2.6% (n ¼ 129
of 5018), of which approximately one third (33%; n ¼ 42
of 129) occurred after hospital discharge. Overall
morbidity rate was 44%. Predischarge complications
occurred in 38% of patients; 11% experienced a post-
discharge complication within 30 days of surgery. Tem-
poral distribution of complications varied according to
speciﬁc complications. SSIs were ﬁve times more likely to
occur after discharge than before discharge (8.6% vs 1.7%),
although all other NSQIP-deﬁned complications were
more likely to occur before discharge. Further, post-
discharge wound complications were seen to occur well
after discharge, with mean date of diagnosis for post-
discharge superﬁcial SSI, deep SSI, and dehiscenceoccurring on postdischarge days 12.6, 14.4, and 10.0,
respectively. Patients with postdischarge complications had
varying rates of readmission, depending on the nature of
the complication.
Bivariate analysis: ReadmissiondNSQIP. Readmis-
sion analyses were performed for 4512 patients (Tables II
and III). Exclusions were made for patients not at risk
for 30-day readmission at the time of discharge (death on
index admission or in the hospital at 30 days; n ¼ 96) and
those for whom readmission data were unavailable (n ¼
410) (Table IV). Overall readmission rate was 18%,
whereas the complication-associated readmission rate was
8%. Factors associated with readmission on bivariate anal-
ysis were primarily patient characteristics and operative
details rather than in-hospital postoperative adverse events.
The only predischarge complication associated with read-
mission on bivariate analysis was postoperative hemor-
rhage, deﬁned as transfusion of 5 units or more of packed
red blood cells within 72 hours postoperatively. Read-
mitted patients were more likely to have a longer length of
postoperative stay and a discharge to a location other than
home than were nonreadmitted patients (Table IV).
Multivariable analysis: ReadmissiondNSQIP. Multi-
variable predictors of overall readmission are shown in
Fig 1. Independent predictors of readmission were
primarily patient related. Postoperative stay longer than
6 days, the study mean, and return to the operating room
on index admission were the lone postoperative predictors.
Return to the operating room also had the largest effect
Table II. Operative variables for LEB patients who underwent readmission analysis in the 2011 NSQIP database
Overall
(N ¼ 4512), No. (%)
Readmitted
(n ¼ 826), No. (%)
Not readmitted
(n ¼ 3686), No. (%) P value
Mean operating room time 6 SD, minutes 225 6 110 243 6 117 221 6 108 <.001
Popliteal inﬂow (vs femoral inﬂow) 374 (8.3) 82 (9.9) 292 (7.9) .069
Popliteal target (vs infrapopliteal target) 1888 (41.8) 403 (48.8) 1485 (40.3) <.001
Synthetic graft (vs vein graft) 1554 (34.4) 276 (33.4) 1278 (34.7) .517
Operative time > 225 minutes (vs < 225 minutes) 2057 (42.1) 422 (51.2) 1470 (40.0) <.001
Emergency casea 252 (5.6) 55 (6.7) 197 (5.3) .154
Elective surgeryb 2988 (67.2) 489 (60.1) 2499 (68.8) <.001
Additional procedure
Fasciotomy 57 (1.3) 9 (1.1) 48 (1.3) .732
Minor amputation 151 (3.3) 36 (4.4) 115 (3.1) .086
Endovascular procedure 536 (11.9) 97 (11.7) 439 (11.9) .953
Additional bypass 132 (2.9) 20 (2.4) 112 (3.0) .423
LEB, Lower extremity bypass; NSQIP, National Surgery Quality Improvement Program; SD, standard deviation.
aCases reported by surgeon and anesthesiologist as emergent; surgery must occur within 12 hours of admission or onset of related preoperative symptoms.
bPatient admitted from home or current living situation on day of previously scheduled surgery.
Table III. Demographic characteristics and comorbidities for LEB patients who underwent readmission analysis in the
2011 NSQIP database
Overall
(N ¼ 4512), No. (%)
Readmitted
(n ¼ 831), No. (%)
Not readmitted
(n ¼ 3763), No. (%) P value
Mean age 6 SD, years 67.4 6 11.5 67.8 6 11.5 67.3 6 11.5 .330
Male 2921 (64.8) 510 (61.7) 2411 (65.5) .044
Race .040
White 3321 (80.1) 592 (76.7) 2729 (80.8)
Black 772 (18.6) 173 (22.4) 599 (17.7)
Asian 38 (0.9) 5 (0.6) 33 (1.0)
Native American 10 (0.2) 1 (0.1) 9 (0.3)
Native Hawaiian/Paciﬁc Islander 7 (0.2) 1 (0.1) 6 (0.2)
Chronic nursing home residence 137 (3.0) 39 (4.7) 98 (2.7) .003
Dependent functional status 473 (10.5) 136 (16.5) 337 (9.2) <.001
Diabetes mellitus 1976 (43.8) 416 (50.4) 1560 (42.3) <.001
Smoker 1911 (42.4) 327 (39.6) 1584 (43.0) .08
Chronic obstructive pulmonary disease 572 (12.7) 127 (15.4) 445 (12.1) .011
Cardiac comorbidity 849 (34.3) 202 (44.2) 647 (32.0) <.001
History of revascularization or amputation 1201 (49.5) 244 (55.3) 957 (48.2) .007
CLI 2092 (65.7) 467 (76.8) 1625 (63.1) <.001
Dialysis dependence 270 (6.0) 86 (10.4) 184 (5.0) <.001
Systemic sepsis .001
SIRS 151 (3.3) 46 (5.6) 105 (2.8)
Sepsis 42 (0.9) 6 (0.7) 36 (1.0)
Septic shock 1 (0) 0 (0) 1 (0)
ASA class $4 923 (20.5) 236 (28.6) 687 (18.6) <.001
Obesity 1243 (27.9) 268 (32.8) 975 (26.8) .001
Malnutrition2 922 (38.6) 246 (51.7) 676 (35.3) <.001
ASA, American Society of Anesthesiologists; CLI, critical limb ischemia; LEB, lower extremity bypass; NSQIP, National Surgery Quality Improvement
Program; SD, standard deviation; SIRS, systemic inﬂammatory response syndrome.
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[CI], 18.6-33.3). Reason for return to the operating room
on index admission (n ¼ 728 of 4922) was not speciﬁcally
available, although 45% (n ¼ 39 of 87) of patients with a
predischarge wound complication and 83% (n ¼ 38 of 46)
of patients with predischarge graft failure were taken back
to the operating room.
Readmission indicationsdNSQIP. Approximately
half of overall readmissions (n ¼ 373 of 826; 45%) were
deﬁned as complication associated in the setting of anNSQIP-deﬁned postdischarge complication. The most
common postdischarge events occurring in readmitted
patients included wound complications (55%), multiple
complications (22%), and graft failure (5%) (Fig 2, a). Of
those with multiple complications, wound infections were
also the most common (n ¼ 54 of 82; 66%), followed by
sepsis (n ¼ 46 of 82; 56%) and pneumonia (n ¼ 12 of 82;
15%) (Fig 2, b).
Readmission indicationsdinstitutional. Our institu-
tion contributed 465 patients undergoing infrainguinal
Table IV. Complications and postoperative outcomes in LEB patients who underwent readmission analysis in the 2011
NSQIP database
Overall
(N ¼ 4512), No. (%)
Readmitted
(n ¼ 826), No. (%)
Not readmitted
(n ¼ 3686), No. (%) P value
Mean length of postoperative stay 6 SD, days 5.9 6 5.4 6.3 6 4.3 5.9 6 5.7 .033
Nonhome discharge 1238 (27.6) 291 (35.4) 947 (25.9) <.001
Any complication 1996 (44.2) 678 (82.1) 1318 (35.8) <.001
Any wound complication 515 (11.4) 306 (37.0) 209 (5.7) <.001
Overall mortality 71 (1.6) 31 (3.8) 40 (1.1) <.001
Myocardial infarction 93 (2.1) 38 (4.6) 55 (1.5) <.001
Bleeding 1235 (27.4) 287 (34.7) 948 (25.6) <.001
Graft failure 79 (1.8) 42 (5.1) 37 (1.0) <.001
Acute kidney injury 24 (0.5) 15 (1.8) 9 (0.2) <.001
Sepsis 105 (2.3) 57 (6.9) 48 (1.3) <.001
Deep venous thrombosis 30 (0.7) 18 (2.2) 12 (0.3) <.001
Pulmonary embolism 9 (0.2) 8 (1.0) 1 (0) <.001
Pneumonia 62 (1.4) 29 (3.5) 33 (0.9) <.001
LEB, Lower extremity bypass; NSQIP, National Surgery Quality Improvement Program; SD, standard deviation.
Fig 1. Independent predictors of readmission for lower extremity
bypass (LEB) patients in the 2011 National Surgery Quality
Improvement Program (NSQIP). CI, Conﬁdence interval; COPD,
chronic obstructive pulmonary disease; OR, operating room.
Fig 2. a, Complications by type among lower extremity bypass
(LEB) patients who were readmitted as recorded in the 2011
National Surgery Quality Improvement Program (NSQIP) cohort.
b, Breakdown of patients with multiple complications. UTI,
Urinary tract infection; VTE, venous thromboembolism.
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tients for either predischarge death or index hospital stay
longer than 30 days, the overall readmission rate for our
institutional patients was 14% (n ¼ 63 of 453). NSQIP-
identiﬁed readmission to any institution (captured after
late 2010) was 16% (n ¼ 18 of 113), although only one of
these readmissions was to an outside institution. Cases
performed before this time were evaluated for readmission
to our institution by physician chart review, yielding a rate
of 13% (n ¼ 45 of 340). The characteristics of our insti-
tutional cohort did differ from the NSQIP cohort with
respect to certain patient demographics. Our institutional
patients were older (70 vs 68 years; P < .001) and more
likely to have CLI (77% vs 66%; P < .001) but less likely to
be American Society of Anesthesiologists class 4 or above
(15% vs 21%; P ¼ .002). Readmissions were unplanned in
89% of cases (n ¼ 56 of 63) and planned in the remainder
(Fig 3, a). Of the 47 patients who required unplanned
readmission, reoperation occurred in 7 cases (15%),
including bypass revision in 3 cases, new bypass in 2 cases,
angioplasty in 1 case, and operative debridement in 1 case.The most common readmission indications (Fig 3, b)
in our patients included wound infection (37%) and graft
failure (10%). Readmission indications grouped under the
other category (28%) included incisional pain, concern for
wound infection, GI bleed, atrial ﬁbrillation, and concern for
stroke. Readmissions were attributable to NSQIP-captured
Fig 3. a, Institutional lower extremity bypass (LEB) readmissions,
by relationship to index procedure. b, Breakdown of institution-
related unplanned LEB readmissions by diagnosis. C diff, Clos-
tridium difﬁcile infection; CHF, congestive heart failure; MI,
myocardial infarction; SSI, surgical site infection.
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An additional 44% had a non-NSQIP-deﬁned reason
for readmission. The remaining 12% included patients
admitted for complications described in NSQIP but not
strictly meeting NSQIP criteria. Some reasons for readmis-
sion not captured by NSQIP were procedure-related com-
plications not deﬁned in NSQIP; others included concern
for a complication or monitoring. Unrelated readmission
indications included a number of varied complaints, such
as vascular complaints related to the contralateral lower ex-
tremity (n ¼ 3 of 9), complication of tooth extraction
(n ¼ 1 of 9), and mechanical fall (n ¼ 1 of 9), among
others. Notably, complaints related to the contralateral
lower extremity, although unrelated to the surgical limb,
are often indistinguishable through the InternationalClassiﬁcation of Diseases, Ninth Revision diagnosis codes,
which lack laterality.
DISCUSSION
This study represents the ﬁrst investigation of a
national, multicenter, prospective clinical database for risk
factors for readmission after LEB. In contradistinction to
prior studies using administrative billing data, such as
Medicare, NSQIP methodology includes direct medical
record review and patient telephone contact speciﬁcally
designed to facilitate quality improvement and clinical out-
comes research. Moreover, in contrast to the prior clinical
studies, the NSQIP methodology captures readmissions
even to non-NSQIP hospitals. Our review of patients
undergoing infrainguinal LEB in the 2011 NSQIP demon-
strated an overall readmission rate of 18% and a
complication-associated readmission rate of 8%. Indepen-
dent risk factors for overall readmission were primarily
patient related (Fig 1). However, return to the operating
room on index admission, the lone postoperative complica-
tion associated with readmission, was associated with the
highest risk for readmission. Whereas more than half of
patients in the NSQIP cohort were readmitted without
an NSQIP-deﬁned postdischarge complication, our institu-
tional data offered greater detail on readmission indication,
conﬁrming SSI as the most common reason for rehospital-
ization while also showing that one quarter of readmissions
were either planned or unrelated to the surgical procedure.
Finally, the NSQIP data emphasize the importance of
30-day outcomes in the study of LEB as one third of deaths
occurred after discharge and more than 10% of patients suf-
fered a postdischarge complication.
Our study’s overall readmission rate of 18% is generally
in agreement with previously published reports for patients
undergoing LEB on the national level in Medicare by
Goodney16 (19%) and in single-institution series by Jack-
son6 (15%) and McPhee17 (25%). However, whereas risk
factors for readmission vary by study, there are many com-
monalities, and the differences may be attributable to study
design and variables considered. Similar to the data of
McPhee,17 who found tissue loss indication and preop-
erative CHF to predict readmission, our data also showed
CLI, dialysis dependence, and cardiac comorbidity
(including CHF) to be independent predictors of rehospi-
talization. Vogel et al,18 in a study of Medicare beneﬁciaries
undergoing catheter-based lower extremity revasculariza-
tion for CLI, further conﬁrmed these associations in
showing gangrene, chronic renal failure, and CHF to be
associated with readmission. In addition, obesity was found
to be associated with readmission in our cohort but was not
explicitly studied in previous reports.
Whereas infrapopliteal target vessel was found to be a
bivariate risk factor for readmission in both our study and
McPhee’s study,17 the McPhee study also found distal
inﬂow source (ie, superﬁcial femoral artery compared with
common femoral artery) to be an independent predictor
of readmission. Although precise inﬂow source was not
available for our analysis (ie, common femoral artery vs
JOURNAL OF VASCULAR SURGERY
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did allow identiﬁcation of those patients with a popliteal ar-
tery inﬂow source compared with femoral. Whereas we saw
a trend toward increased readmission with these patients
(21.9% vs 18.0%; P ¼ .069), it did not reach statistical
signiﬁcance.
Finally, predischarge complications including wound
infection, graft failure, and myocardial infarction predicted
readmission in the McPhee study,17 whereas only return to
the operating room on index admission showed such an
association in our report, albeit an association with greatest
risk for readmission (odds ratio, 8; 95% CI, 7-10). Our
study showed 28-fold risk increase (95% CI, 13-62) in reop-
eration for patients experiencing predischarge graft failure
and a 5-fold risk increase (95% CI, 3-8) in reoperation for
patients suffering a predischarge wound complication. In
our view, this ﬁnding reﬁnes the previous data to suggest
that those predischarge complications of sufﬁcient severity
to warrant a return to the operating room have the highest
risk for readmission and delineate a very high risk group.
Patients with the aforementioned risk factors, including
patients operated on for CLI, patients with poor baseline
health, and those patients requiring return to the operating
room on the index admission, constitute a group at
increased risk for readmission. Yet, despite recognition of
this high-risk status, these risk factors offer minimal oppor-
tunity in terms of actionable quality improvement targets.
Although many of these risk factors are either not modiﬁ-
able or minimally modiﬁable in the short term, we should
nonetheless ensure that certain of these, such as obesity,
malnutrition, and cardiac function, are optimized preoper-
atively in our patients. Indication for readmission in our
institutional contribution to the NSQIP was primarily
related unplanned (75%; n ¼ 47 of 63). With 53% (n ¼
25 of 47) of unplanned readmissions related to wound
complications, our institutional data reinforce the ﬁndings
of McPhee et al17 (63%) in showing wound complications
to account for the largest proportion of unplanned read-
missions. This ﬁgure exceeds the 25% of overall readmis-
sions attributable to wound complications in the NSQIP.
This may be related to speciﬁc aspects of the NSQIP deﬁ-
nitions for wound infection. Interestingly, 9% (n ¼ 4 of 47)
of unplanned readmissions in our institutional series were
related to concern for a wound infection that was not ulti-
mately categorized as a wound infection. This points to the
need for improved monitoring with perhaps improved use
of skilled outpatient nursing or electronic transmission of
wound images, as is being studied in select centers. There
has been recent interest in use of outpatient nursing and
electronic transmission of wound images to prevent confu-
sion about medications and to spot developing symptoms
and issues before they progress in severity. Some centers
have employed nurse-conducted telephone calls after
discharge to see whether this would reduce readmission
rates. We are currently advocating for the electronic trans-
mission of wound images provided either by the patient or
by the visiting nurse at select intervals to detect wound in-
fections at an early stage.The high proportion of readmissions related to postdi-
scharge SSI points to prevention of SSI as a means of
decreasing unplanned readmissions. A 2011 report by
Greenblatt et al24 evaluated risk factors for 30-day SSI after
LEB in the NSQIP from 2005 to 2008. Whereas a number
of baseline patient characteristics, including female sex,
dialysis dependence, and others, predicted SSI in their
study, operative time of longer than 4 hours was the
lone modiﬁable risk factor, conferring a 40% increased
risk of SSI. Greenblatt et al24 speculated that deﬁciencies
in timely readministration of prophylactic antibiotics,
hypothermia, and other factors may play a role in the
development of SSI after long operations. Further empha-
sizing the importance of operative technique in SSI risk, a
recent study from the Vascular Study Group of New
England database by Tan et al25 found that perioperative
blood transfusion was an independent risk factor for SSI,
with those patients receiving 3 units or more of perioper-
ative packed red blood cells at more than threefold
increased risk for SSI. These studies suggest that intraoper-
ative management, including judicious use of blood trans-
fusion, may play a role in diminishing postoperative SSI
and hospital readmissions.
As was the case in the report byMcPhee et al,17 who saw
a longer length of stay for readmitted patients compared
with nonreadmitted patients (12.2 vs 10.2 days; P <
.001), patients readmitted after LEB in the NSQIP also
had a longer length of postoperative stay than did nonread-
mitted patients (6.3 vs 5.9 days; P ¼ .033). However,
different from the report byMcPhee et al, our study showed
length of postoperative stay longer than 6 days, the study
mean, to independently predict readmission. Yet, despite
this ﬁnding, the timing of postdischarge adverse events sug-
gests that an additional day or two in the hospital may be
unlikely to prevent readmission. For example, as noted in
the NSQIP morbidity and mortality section of the results,
postdischarge wound infections occurred, on average,
more than a week after leaving the hospital. This argues
against the beneﬁt of a marginal increase in length of stay
to decrease the incidence of readmission.
Planned readmission rate was 1.5% (n ¼ 7 of 465),
which was in line with the study of McPhee et al,17 who
showed a 2.7% planned readmission rate. Notably, one
quarter of readmissions were related planned (11%; n ¼ 7
of 63) or unrelated (14%; n ¼ 9 of 63). This underscores
the difﬁculty in altering reimbursement patterns for read-
missions after vascular surgery as a fourth of these readmis-
sions are not true complication-related readmissions and
would thus incur an inappropriate penalty if reimbursement
is based solely on overall readmission rate. In addition,
many patients being readmitted with complications we
thought to be related to the procedure did not have a cor-
responding NSQIP category for that complication, such as
Clostridium difﬁcile infection, hematoma, pain, atrial ﬁbril-
lation, and gastrointestinal bleed. Adding these categories
to the NSQIP may help provide more detailed feedback
to participating institutions about their procedure-related
complications. Furthermore, we suggest that it would be
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speciﬁc indications for readmission as these data may help
reduce readmission and unearth issues that may provide
insight into postoperative care. As the approach to the issue
of readmission after LEB continues to evolve, care must be
taken to ensure that robust mechanisms are in place to
discern the relationship of a readmission to the index pro-
cedure, particularly in the case of contralateral limb disease,
which cannot be distinguished from ipsilateral limb disease
on the basis of the International Classiﬁcation of Diseases,
Ninth Revision codes alone.
These ﬁndings must be interpreted in the context of
the study design. Our study relies on a prospectively
collected clinical database and as such may collect only
data that are available within the normal course of clinical
care. Given this fact, certain data, such as albumin level,
are not routinely checked and may be missing from patients
in whom these measurements were not deemed indicated.
To the extent that these decisions may be made in a non-
differential fashion, we cannot make reliable determina-
tions about the effect of certain parameters for which we
have incomplete data. In this study, we found albumin level
to be such a parameter and thus cannot make ﬁrm state-
ments about the effect of albumin level on readmission.
In addition, the NSQIP database was conceived for broad
applicability to a wide variety of surgical procedures and as
such does not contain granular detail speciﬁcally related to
vascular surgery. The next iteration of the NSQIP, which
has already begun accruing data, has parameters speciﬁc
to vascular surgery that may enrich future studies. It is
for this reason that we relied on a retrospective review of
our institutional data to further clarify indications for read-
mission in this population. Our single-institution retrospec-
tive review is missing readmission to other institutions
before 2010, and although this is a potential weakness of
our study, only one readmission of 18 after 2010 was to
another institution, indicating that the number of readmis-
sions to outside institutions was likely to be a small minor-
ity. Although our institutional data were subjected to
physician chart review to deﬁne the relationship of the
readmission to the index procedure, this process carries a
degree of subjectivity that we think makes determination
of reimbursement, or lack thereof, in this setting fraught
with uncertainty.
CONCLUSIONS
This study of patients undergoing LEB, the largest
review of clinical, nonadministrative data related to this
procedure, has further deﬁned a population at increased
risk for readmission. Patients with poor baseline health
and, in particular, patients requiring return to the operating
room on their index admission represent a group that may
beneﬁt from improved follow-up mechanisms, particularly
in light of a high incidence of postdischarge mortality.
Moreover, we have reinforced the ﬁndings of prior reports
that found postdischarge SSI to be associated with rehospi-
talization. Surgeon-controlled risk factors, such as opera-
tive time and perioperative blood transfusion, may play arole in mitigating these SSIs. Further, we hypothesize
that early detection of SSIs through improved monitoring
may aid in early detection of SSI and possibly decrease
the need for readmission. Although data on postoperative
patient outreach to date have been mixed, innovation in
this regard could play a large role in improving outcomes.
Finally, we have shown that a signiﬁcant number of read-
missions are either planned or unrelated to the index pro-
cedure, which suggests that reimbursement models
assessing a penalty for readmission should be implemented
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